At a glance
ClinicalIndex Comparison RecordN/ACompleted· 3,000 enrolled
Drug / intervention
endovascular treatmentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
enDovascular trEatmenT for acutE isChemic sTroke in China (DETECT2-China): a Prospective, National, Multi-center, Registry Study
In Brief
An observational study evaluating endovascular treatment for Stroke, Ischemic. Completed, enrolled 3,000 participants across 1 site.
Detailed Summary
This is a prospective real world registry study, aiming to explore the effectiveness and safety of endovascular treatment of acute ischemic stroke in a Chinese population.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsStroke, Ischemic
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedOct 2021
Enrollment StartJan 2022
Primary CompletionJan 2025
TodayJul 2026
First PostedOct 25, 2021
Enrollment StartJan 21, 2022
Primary CompletionJan 10, 2025
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 4.7 years ago
Interventions
endovascular treatmentdevice
all enrolled patients must receive endovascular treatment